Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jan 2022 for Ikena Oncology, Inc., €68. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Xiaoyan Michelle Zhang: trading record in brief
Xiaoyan Michelle Zhang (senior executive) discloses dealings in ImageneBio, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 10 December 2021 to 10 January 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 12 January 2022 with an option exercise (€68) in ImageneBio, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Xiaoyan Michelle Zhang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
36 shares@ US$2.14623.5% of flowCommon StockSEC:0000899243-22-001806:0
1,000 shares@ US$2.146296.5% of flowCommon StockSEC:0000899243-21-048230:0
2 of 2 declarations
